Prof. Dr. Beat Thürlimann
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Perey L, Goldhirsch A, Köberle D, Clément P, Dietrich D, Fiche M, Wildiers H, Nolé F, Zaman K, Hawle H, Paridaens R, Thürlimann B. Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00). Ann Oncol 2007; 18:64-9.
01.01.2007Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
01.01.2007Ann Oncol 2007; 18:64-9
Perey L, Goldhirsch A, Köberle Dieter, Clément P, Dietrich D, Fiche M, Wildiers H, Nolé F, Zaman K, Hawle H, Paridaens R, Thürlimann Beat
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
Köberle D, Thürlimann B. Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98. Breast Cancer Res Treat 2007; 105 Suppl 1:55-66.
01.01.2007Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
01.01.2007Breast Cancer Res Treat 2007; 105 Suppl 1:55-66
Köberle Dieter, Thürlimann Beat
Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations
Thürlimann B, Köberle D, Senn H. Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations. EJC 2007; 43:46-52.
01.01.2007Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations
01.01.2007EJC 2007; 43:46-52
Thürlimann Beat, Köberle Dieter, Senn Hans-Joerg
Die Primärbehandlung des frühen Mammakarzinoms
Kapp U, Fürstenberger G, Thürlimann B. Die Primärbehandlung des frühen Mammakarzinoms - Internationale St. Gallen-Konsensus Konferenz 2007. Schweizer Zeitschrift für Onkologie 2007; 4:6-10.
01.01.2007Die Primärbehandlung des frühen Mammakarzinoms
01.01.2007Schweizer Zeitschrift für Onkologie 2007; 4:6-10
Kapp U, Fürstenberger G, Thürlimann Beat
Brustzentren in der Schweiz
Thürlimann B. Brustzentren in der Schweiz. Schweizer Zeitschrift für Onkologie 2007; 4:22-23.
01.01.2007Brustzentren in der Schweiz
01.01.2007Schweizer Zeitschrift für Onkologie 2007; 4:22-23
Thürlimann Beat
First--select the target: better choice of adjuvant treatments for breast cancer patients
Goldhirsch A, Coates A, Gelber R, Glick J, Thürlimann B, Senn H, St Gallen Expert Panel Members. First--select the target: better choice of adjuvant treatments for breast cancer patients. Ann Oncol 2006; 17:1772-6.
01.12.2006First--select the target: better choice of adjuvant treatments for breast cancer patients
01.12.2006Ann Oncol 2006; 17:1772-6
Goldhirsch A, Coates A S, Gelber R D, Glick J H, Thürlimann Beat, Senn H-J, St Gallen Expert Panel Members
Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis
Langenegger T, Wahl P, Schiesser D, Thürlimann B. Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis. Breast Cancer Res Treat 2006; 100:177-81.
01.11.2006Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis
01.11.2006Breast Cancer Res Treat 2006; 100:177-81
Langenegger T, Wahl P, Schiesser D, Thürlimann Beat
The multidisciplinary meeting: An indispensable aid to communication between different specialities
Ruhstaller T, Roe H, Thürlimann B, Nicoll J. The multidisciplinary meeting: An indispensable aid to communication between different specialities. EJC 2006; 42:2459-62.
01.10.2006The multidisciplinary meeting: An indispensable aid to communication between different specialities
01.10.2006EJC 2006; 42:2459-62
Ruhstaller Thomas, Roe Helen, Thürlimann Beat, Nicoll Jonathan J
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
Glaus A, Böhme C, Thürlimann B, Ruhstaller T, Hsu Schmitz S, Morant R, Senn H, von Moos R. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 2006; 17:801-6.
01.05.2006Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
01.05.2006Ann Oncol 2006; 17:801-6
Glaus A, Böhme Christel, Thürlimann Beat, Ruhstaller Thomas, Hsu Schmitz S F, Morant R, Senn H J, von Moos R
Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn H, Hamacher J, Boneberg E. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. BJC 2006; 94:524-31.
27.02.2006Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
27.02.2006BJC 2006; 94:524-31
Fürstenberger G, von Moos R, Lucas R, Thürlimann Beat, Senn H-J, Hamacher J, Boneberg E-M
Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
Köberle D, Thürlimann B. Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer. Expert review of anticancer therapy 2006; 6:5-10.
01.01.2006Letrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer
01.01.2006Expert review of anticancer therapy 2006; 6:5-10
Köberle Dieter, Thürlimann Beat
Übersicht Bisphosphonate
Maschke U, Kränzlin M, Krapf R, Pecherstorfer M, Strebel U, Thürlimann B. Übersicht Bisphosphonate. Pharmakritik 2006; 28:17-20.
01.01.2006Übersicht Bisphosphonate
01.01.2006Pharmakritik 2006; 28:17-20
Maschke U.P., Kränzlin M, Krapf R, Pecherstorfer M, Strebel U, Thürlimann Beat
Aromatasehemmer in der modernen Brustkrebstheraphie
Thürlimann B. Aromatasehemmer in der modernen Brustkrebstheraphie. Bulletin Leben wie zuvor 2006; 66:19-22.
01.01.2006Aromatasehemmer in der modernen Brustkrebstheraphie
01.01.2006Bulletin Leben wie zuvor 2006; 66:19-22
Thürlimann Beat
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
Breast International Group (BIG) 1-98 Collaborative Group, Price K, Wardly A, Wardley A, Smith I, Rabaglio M, Gelber R, Castiglione-Gertsch M, Paridaens R, Forbes J, Mauriac L, Mouridsen H, Coates A, Keshaviah A, Thürlimann B, Goldhirsch A. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. NEJM 2005; 353:2747-57.
29.12.2005A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
29.12.2005NEJM 2005; 353:2747-57
Breast International Group (BIG) 1-98 Collaborative Group, Price Karen N, Wardly Andrew, Wardley Andrew, Smith Ian, Rabaglio Manuela, Gelber Richard D, Castiglione-Gertsch Monica, Paridaens Robert, Forbes John F, Mauriac Louis, Mouridsen Henning, Coates Alan S, Keshaviah Aparna, Thürlimann Beat, Goldhirsch Aron
Adjuvant endocrine therapy in postmenopausal breast cancer patients
Köberle D, Thürlimann B. Adjuvant endocrine therapy in postmenopausal breast cancer patients. Breast (Edinburgh, Scotland) 2005; 14:446-51.
01.12.2005Adjuvant endocrine therapy in postmenopausal breast cancer patients
01.12.2005Breast (Edinburgh, Scotland) 2005; 14:446-51
Köberle Dieter, Thürlimann Beat
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
Gruber G, Goldhirsch A, Coates A, Gelber R, Fey M, Simoncini E, Thürlimann B, Carbone A, Crivellari D, Collins J, Golouh R, Lindtner J, Holmberg S, Rudenstam C, Castiglione-Gertsch M, Price K, Nasi M, Bonetti M, International Breast Cancer Study Group. Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI. JCO 2005; 23:7089-97.
01.10.2005Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
01.10.2005JCO 2005; 23:7089-97
Gruber Günther, Goldhirsch Aron, Coates Alan S, Gelber Richard D, Fey Martin F, Simoncini Edda, Thürlimann Beat, Carbone Antonino, Crivellari Diana, Collins John, Golouh Rastko, Lindtner Jurij, Holmberg Stig B, Rudenstam Carl-Magnus, Castiglione-Gertsch Monica, Price Karen N, Nasi M Laura, Bonetti Marco, International Breast Cancer Study Group
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
Goldhirsch A, Glick J, Gelber R, Coates A, Thürlimann B, Senn H, Panel members. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16:1569-83.
01.10.2005Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
01.10.2005Ann Oncol 2005; 16:1569-83
Goldhirsch A, Glick J H, Gelber R D, Coates A S, Thürlimann Beat, Senn H-J, Panel members
Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer
Pagani O, Longhi S, Ruggeri M, Graffeo R, Hess D, Thürlimann B, Lombardi D, Crivellari D, Munzone E, Nolé F, Sessa C, Goldhirsch A. Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer. Ann Oncol 2005; 16:1609-17.
01.10.2005Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer
01.10.2005Ann Oncol 2005; 16:1609-17
Pagani O, Longhi S, Ruggeri M, Graffeo R, Hess D, Thürlimann Beat, Lombardi D, Crivellari D, Munzone E, Nolé F, Sessa C, Goldhirsch A
[Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]
Thürlimann B, Senn H. [Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]. Gynäkologisch-geburtshilfliche Rundschau 2005; 45:143-6.
01.06.2005[Consensus Meeting of the 9th International Conference on Primary Therapy of Early Breast Cancer (St. Gall, January 26-29, 2005)]
01.06.2005Gynäkologisch-geburtshilfliche Rundschau 2005; 45:143-6
Thürlimann Beat, Senn H J
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
Colleoni M, Veronesi A, Holmberg S, Erzen D, Forbes J, Murray E, Thürlimann B, Simoncini E, Pagani O, Collins J, Crivellari D, Rudenstam C, Lindtner J, Price K, Castiglione-Gertsch M, Coates A, Gelber R, Li S, Goldhirsch A. Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor. Ann Oncol 2005; 16:716-25.
01.05.2005Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor
01.05.2005Ann Oncol 2005; 16:716-25
Colleoni M, Veronesi A, Holmberg S, Erzen D, Forbes J, Murray E, Thürlimann Beat, Simoncini E, Pagani O, Collins J, Crivellari D, Rudenstam C-M, Lindtner J, Price K N, Castiglione-Gertsch M, Coates A S, Gelber R D, Li S, Goldhirsch A